Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CSPC Pharmaceutical Group...

    OTC: CSPCY · Real-Time Price · USD
    4.54
    -0.03 (-0.66%)
    At close: Jun 13, 2025, 2:26 PM

    CSPC Pharmaceutical Statistics

    Share Statistics

    CSPC Pharmaceutical has 2.89B shares outstanding. The number of shares has increased by -2.88% in one year.

    Shares Outstanding

    n/a
    		 2.89B

    Shares Change (YoY)

    n/a
    		 -2.88%

    Shares Change (QoQ)

    n/a
    		 -1.72%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 7.93B

    Failed to Deliver (FTD) Shares

    n/a
    		 14,250

    FTD / Avg. Volume

    n/a
    		 60.42%

    Short Selling Information

    The latest short interest is 77, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 77

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is 12.43 and the forward PE ratio is null. CSPC Pharmaceutical's PEG ratio is -0.39.

    PE Ratio

    n/a
    		 12.43

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 1.85

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 1.67

    P/FCF Ratio

    n/a
    		 28.99

    PEG Ratio

    n/a
    		 -0.39
    Financial Ratio History

    Enterprise Valuation

    CSPC Pharmaceutical has an Enterprise Value (EV) of 208.91B.

    EV / Sales

    n/a
    		 7.2

    EV / EBITDA

    n/a
    		 30.01

    EV / EBIT

    n/a
    		 46.07

    EV / FCF

    n/a
    		 112.57

    Financial Position

    The company has a current ratio of 2.27, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 2.27

    Quick Ratio

    n/a
    		 1.95

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 0.07

    Debt / FCF

    n/a
    		 0.27

    Interest Coverage

    n/a
    		 122.87

    Financial Efficiency

    Return on Equity is 13.41% and Return on Invested Capital is 11.85%.

    Return on Equity

    n/a
    		 13.41%

    Return on Assets

    n/a
    		 9.75%

    Return on Invested Capital

    n/a
    		 11.85%

    Revenue Per Employee

    n/a
    		 $1,355,572.62

    Profits Per Employee

    n/a
    		 $202,244.63

    Employee Count

    n/a
    		 21,400

    Asset Turnover

    n/a
    		 0.65

    Inventory Turnover

    n/a
    		 2.78

    Taxes

    Income Tax

    n/a
    		 1.24B

    Effective Tax Rate

    n/a
    		 22.23%

    Stock Price Statistics

    The stock price has increased by 32.08% in the last 52 weeks. The beta is 0.78, so CSPC Pharmaceutical's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.78

    52-Week Price Change

    n/a
    		 32.08%

    50-Day Moving Average

    n/a
    		 3.18

    200-Day Moving Average

    n/a
    		 2.71

    Relative Strength Index (RSI)

    n/a
    		 80.66

    Average Volume (20 Days)

    n/a
    		 23,584

    Income Statement

    In the last 12 months, CSPC Pharmaceutical had revenue of 29.01B and earned 4.33B in profits. Earnings per share was 1.48.

    Revenue

    n/a
    		 29.01B

    Gross Profit

    n/a
    		 20.3B

    Operating Income

    n/a
    		 5.37B

    Net Income

    n/a
    		 4.33B

    EBITDA

    n/a
    		 6.96B

    EBIT

    n/a
    		 5.62B

    Earnings Per Share (EPS)

    n/a
    		 1.48
    Full Income Statement

    Balance Sheet

    The company has 6.78B in cash and 507.33M in debt, giving a net cash position of 6.27B.

    Cash & Cash Equivalents

    n/a
    		 6.78B

    Total Debt

    n/a
    		 507.33M

    Net Cash

    n/a
    		 6.27B

    Retained Earnings

    n/a
    		 23.34B

    Total Assets

    n/a
    		 44.39B

    Working Capital

    n/a
    		 12.25B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 4.53B and capital expenditures -2.68B, giving a free cash flow of 1.86B.

    Operating Cash Flow

    n/a
    		 4.53B

    Capital Expenditures

    n/a
    		 -2.68B

    Free Cash Flow

    n/a
    		 1.86B

    FCF Per Share

    n/a
    		 0.16
    Full Cash Flow Statement

    Margins

    Gross margin is 69.97%, with operating and profit margins of 18.5% and 14.92%.

    Gross Margin

    n/a
    		 69.97%

    Operating Margin

    n/a
    		 18.5%

    Pretax Margin

    n/a
    		 19.23%

    Profit Margin

    n/a
    		 14.92%

    EBITDA Margin

    n/a
    		 24%

    EBIT Margin

    n/a
    		 18.5%

    FCF Margin

    n/a
    		 6.4%

    Dividends & Yields

    CSPCY pays an annual dividend of $0.13, which amounts to a dividend yield of 3.52%.

    Dividend Per Share

    n/a
    		 $0.13

    Dividend Yield

    n/a
    		 3.52%

    Dividend Growth (YoY)

    n/a
    		 -28.58%

    Payout Ratio

    n/a
    		 63.53%

    Earnings Yield

    n/a
    		 8.05%

    FCF Yield

    n/a
    		 0.86%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for CSPCY.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $7.4

    Lynch Upside

    n/a
    		 61.93%

    Graham Number

    n/a
    		 4.78

    Graham Upside

    n/a
    		 4.6%

    Stock Splits

    The last stock split was on Dec 10, 2020. It was a forward split with a ratio of 8:5.

    Last Split Date

    n/a
    		 Dec 10, 2020

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 8:5

    Scores

    Altman Z-Score

    n/a
    		 3.2

    Piotroski F-Score

    n/a
    		 8

    Add to Watchlist